Skip to content

Efficacy Evaluation of Acupuncture in Patients with Poor Ovarian Response: A Randomized Controlled Trial

Efficacy Evaluation of Acupuncture in Patients with Poor Ovarian Response: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000810
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-04-23
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poor ovarian response,POR

Interventions

Acupuncture Group 2:IVF treatment
Superficial needling at sham points
Acupuncture Group 1:IVF treatment
Control group:IVF treatment

Sponsors

West China Second University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 39 Years

Inclusion criteria

Inclusion criteria: (1) Aged 21 to <40 years; (2) Meet the diagnostic criteria for poor ovarian response (POR); (3) Voluntarily agree to participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) History of ovarian surgery, radiotherapy, or chemotherapy; (2) Severe primary systemic diseases (e.g., cardiovascular or cerebrovascular diseases, hepatic or renal dysfunction); (3) Chromosomal abnormalities; (4) Contraindications for acupuncture, including bleeding disorders or susceptibility to infections; severe allergies; skin ulcers or scars at acupuncture sites; or needle phobia; (5) Recurrent miscarriage (including biochemical pregnancies) with =2 episodes; (6) Recurrent implantation failure (RIF), defined as failure to achieve clinical pregnancy after at least 3 embryo transfer cycles or cumulative transfer of =10 high-quality embryos; (7) Uterine malformations (e.g., unicornuate uterus, bicornuate uterus, or untreated uterine septum) or untreated conditions impairing the endometrial cavity (e.g., adenomyosis, submucosal fibroids, intrauterine adhesions, uterine scarring); (8) Received acupuncture treatment within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Number of Oocytes Retrieved;

Secondary

MeasureTime frame
number of mature oocytes;2PN rate;Chemical Pregnancy;E2 level on HCG day;follicle-stimulating hormone;Usable embryo rate;clinical pregnancy;Ongoing pregnancy rate;Number of 2PN zygotes ;Endometrial thickness on HCG day;Antral Follicle Counting;Number of MII oocytes;Live birth rate;Cycle cancellation rate;Early pregnancy loss rate;anti-Mullerian hormone;High-quality embryo rate;Embryo implantation rate;Number of follicles =14mm on HCG day;

Countries

China

Contacts

Public ContactJia Liu

West China Second University Hospital

cdutcmysy@gmail.com18180602176

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026